Analysen von Graham Parry
| 22.10.19 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 13.09.19 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 10.09.18 | Sanofi buy | Merrill Lynch & Co., Inc. | |
| 10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Sanofi Neutral | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novartis Underperform | Merrill Lynch & Co., Inc. | |
|
Werbung
|
|||
| 20.05.15 | GSK Underperform | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Roche buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Sanofi Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | GSK Underperform | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 07.07.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 10.03.14 | Sanofi buy | Merrill Lynch & Co., Inc. | |
| 21.10.10 | Novartis buy | Banc of America Securities-Merrill Lynch | |
| 06.09.10 | Sanofi buy | Banc of America Securities-Merrill Lynch | |
| 07.09.10 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 20.08.10 | Sanofi buy | Banc of America Securities-Merrill Lynch | |
| 27.07.10 | Sanofi buy | Banc of America Securities-Merrill Lynch | |